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Preventive  treatment  of  high-risk  asymptomatic  individuals  requires  preliminary  accurate
prediction  of  their  probability  of  developing  a  future  cardiovascular  event.  Non-invasive
detection  of  subclinical  atherosclerosis  by  peripheral  artery  echo-Doppler  or  computed
tomography  (CT)-assessed  coronary  artery  calciﬁcations  (CAC)  aims  at  improving  the  pre-
dictive  value  of  traditional  risk  assessment  as  provided  by  the  Framingham  risk  score  (FRS)
or  its  derived  risk  charts  [1—4]. B-mode  ultrasonographically  assessed  carotid  intima-media
thickness  (CIMT)  is  an  inexpensive,  non-invasive,  precise  and  reproducible  artery  wall
marker.  It  is  predictive  of  subsequent  coronary  heart  disease  and  stroke  [5,6], the  two
leading  causes  of  cardiovascular  death.  For  these  reasons,  in  both  North  American  [2]  and
European  [3,4]  guidelines  for  cardiovascular  disease  (CVD)  prevention,  CIMT  measurement
is  encouraged  for  the  detection  of  subjects  at  high  risk  of  coronary  heart  disease  among
asymptomatic  individuals  at  apparently  intermediate  risk.  The  strength  of  the  added  value
of  CIMT  in  cardiovascular  prediction  remains  questionable,  however,  and  solid  evidence  on
its  usefulness  is  still  lacking  for  applying  these  recommendations  in  clinical  practice.
It  is  well  recognized  that  CIMT  is  associated  with  most  of  the  traditional  cardiovascular
risk  factors,  emerging  biomarkers  and  other  subclinical  cardiovascular  alterations  or  organ
damage  (for  further  information,  see  Simon  et  al.  [5]).  CIMT  is  thus  considered  an  early
integrator  of  the  effects  of  multiple  risk  factors  on  the  arterial  wall  [5].  Also,  a  large
number  of  prospective  studies  have  demonstrated  that  carotid  artery  intima-medial  wall
thickening  is  predictive  of  major  cardiovascular  events,  independently  of  traditional  risk
factors,  with  risk  ratios  ranging  from  1.4  to  5.1  for  coronary  heart  disease,  and  from  2.0
to  3.5  for  stroke  [5—8]. Because  of  its  established  predictive  value  and  its  quantitative
measurement  with  high  precision  and  reproducibility  rates,  CIMT  is  also  being  employed  as
a  surrogate  endpoint  in  numerous  clinical  trials  involving  lipid-lowering  or  antihypertensive
drugs  [5].
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Nevertheless,  conﬂicting  results  have  been  published
mong  studies  on  the  added  value  of  CIMT  measurements
n  cardiovascular  risk  prediction.  These  differences  may
ccount  for  methodological  heterogeneities  across  cohorts
n  terms  of  study  design,  segments  chosen  for  CIMT  mea-
urement  (common,  bifurcation,  internal  carotid  artery),
nclusion  or  exclusion  of  plaques,  cut-off  values  for  risk
ategories,  and  deﬁnition  and  incidence  of  cardiovascular
ndpoints  [6,8]. Recent  epidemiological  advances  indicate
hat  it  is  not  sufﬁcient  that  a  biomarker  provides  indepen-
ent  signiﬁcant  hazards  ratio  associated  with  CVD  incidence:
he  strengths  of  its  predictive  value  also  requires  that
t  carries  powerful  discrimination  and  reclassiﬁcation  [9].
iscrimination  refers  to  the  ability  of  a  biomarker  to  sepa-
ate  adequately  those  subjects  who  will,  from  those  who
ill  not,  develop  an  overt  CVD.  It  can  be  assessed  by
he  area  under  the  curve  (AUC)  of  the  receiving  operating
haracteristic  (ROC)  curve,  or  c-statistic,  which  incorpo-
ates  the  sensitivity  and  speciﬁcity  of  the  biomarker’s
redictive  power  against  the  observed  events  [9].  Reclas-
iﬁcation  assesses  the  proportion  of  individuals  adequately
oved  between  risk  categories  by  the  application  of  the
iomarker  [9].  It  can  be  expressed  as  the  net  reclassiﬁ-
ation  improvement  (NRI)  index,  summing  the  proportion
f  patients  with  an  event  reclassiﬁed  as  at  high  risk  and
hat  of  event-free  subjects  reclassiﬁed  as  at  low  risk
9].
In  2012,  the  weakness  of  CIMT  for  predicting  cardio-
ascular  risk  was  illustrated  by  two  major  publications
8,10].  The  USE-IMT  meta-analysis  was  based  on  data  from
5,828  individuals  from  14  cohort  studies  worldwide  with
 median  follow-up  of  11  years  [8].  The  lack  of  discrimi-
ation  power  was  illustrated  by  the  negligible  increase  in
-statistic  AUC,  by  only  0.002  for  total  CVD-event  prediction
ith  FRS  +  CIMT  vs  FRS  alone  (0.759  vs  0.757,  respectively).
imilarly,  only  a  small  proportion  of  subjects  were  cor-
ectly  upgraded  or  downgraded  from  the  intermediate-risk
ategory  (NRI  =  3.2%  in  men  and  3.9%  in  women)  [8].  The
ulti-Ethnic  Study  of  Atherosclerosis  (MESA)  investigators
ompared  the  improvement  in  6.7-year  CVD  prediction  of
ix  risk  markers  (CT-assessed  CAC,  CIMT,  ankle-brachial
ndex,  brachial  ﬂow-mediated  vasodilation,  high-sensitivity
-reactive  protein  and  family  history  of  coronary  heart
isease)  within  intermediate-risk  participants  (FRS  =  5—20%
t  10  years)  [10]. Again  in  this  study,  CIMT  increased
odestly  the  c-statistic  AUC  from  0.623  (FRS  alone)  to
.652  (FRS  +  CIMT),  similar  to  the  other  markers,  with  the
xception  of  CAC,  which  showed  the  highest  increment  in
UC  up  to  0.784.  Consistently,  few  intermediate-risk  sub-
ects  were  appropriately  reclassiﬁed  by  CIMT  (NRI  =  6%),
imilar  to  other  markers,  which  the  exception  of  CAC,
hich  reclassiﬁed  adequately  46.6%  of  intermediate-risk
ubjects.
Carotid  artery  plaque  may  be  a  better  predictive  marker
han  CIMT.  Indeed,  when  measured  in  the  common  carotid
rtery  usually  free  from  atherosclerotic  plaque,  CIMT  is  not  a
peciﬁc  marker  of  the  atherosclerotic  process,  but  it  reﬂects
edial  hypertrophy,  particularly  as  a  consequence  of  hyper-ension  or  ageing  [5].  Accordingly,  polled  data  from  several
ongitudinal  studies  showed  that  the  absolute  risk  of  coro-
ary  heart  disease  at  10  years  associated  with  the  presence
f  carotid  plaque  was  25%  (high  risk),  compared  with  8%  (lowG.  Chironi,  A.  Simon
isk)  in  the  absence  of  plaque,  contrasting  with  an  abso-
ute  risk  of  11  to  15%  (still  intermediate  risk)  in  subjects
ith  CIMT  >  95th  percentile  [11]. Additionally,  the  Framing-
am  investigators  recently  showed  that  the  maximal  CIMT  of
he  internal  carotid  artery  (potentially  integrating  plaque)
dded  predictive  value  to  FRS  alone,  whereas  the  mean
IMT  of  the  common  carotid  artery  did  not  [12]. Similarly,
he  Atherosclerosis  Risk  In  Communities  (ARIC)  investiga-
ors  found  that  plaque  information,  in  addition  to  CIMT,
esulted  in  a  NRI  of  9.9%  in  a  general  multiethnic  population
13].
Technological  progress,  the  availability  of  ultrasound
quipment  and  the  reliability  and  simplicity  of  the  method,
ave  allowed  the  widespread  use  of  CIMT  measurement  for
tratifying  cardiovascular  risk.  Obviously,  CIMT  remains  of
ajor  interest  for  physiopathological  studies  and  clinical
rials.  However,  the  current  recommendation  to  measure
IMT  in  order  to  reclassify  intermediate-risk  subjects  [2—4]
s  not  supported  by  its  actual  predictive  value,  which
uffers  established  weakness  beyond  traditional  risk  factors
ompared  with  that  of  carotid  plaque  and  coronary  artery
alcinosis.
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